Menu
GeneBe

ABCA7

ATP binding cassette subfamily A member 7, the group of ATP binding cassette subfamily A

Basic information

Region (hg38): 19:1039996-1065572

Links

ENSG00000064687NCBI:10347OMIM:605414HGNC:37Uniprot:Q8IZY2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Alzheimer disease 9 (Limited), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ABCA7 gene.

  • not provided (105 variants)
  • Inborn genetic diseases (99 variants)
  • Alzheimer disease 9 (19 variants)
  • not specified (7 variants)
  • ABCA7-related condition (5 variants)
  • Primary degenerative dementia of the Alzheimer type, presenile onset (1 variants)
  • Amyotrophic lateral sclerosis (1 variants)
  • Frontotemporal dementia;Primary degenerative dementia of the Alzheimer type, presenile onset (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCA7 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
21
clinvar
7
clinvar
29
missense
121
clinvar
20
clinvar
12
clinvar
153
nonsense
1
clinvar
3
clinvar
4
start loss
0
frameshift
5
clinvar
3
clinvar
1
clinvar
1
clinvar
10
inframe indel
0
splice donor/acceptor (+/-2bp)
3
clinvar
3
clinvar
6
splice region
1
5
2
8
non coding
3
clinvar
4
clinvar
7
Total 1 11 128 45 24

Highest pathogenic variant AF is 0.0000329

Variants in ABCA7

This is a list of pathogenic ClinVar variants found in the ABCA7 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-1041353-A-G ABCA7-related disorder Benign (Mar 29, 2019)3060463
19-1041388-G-A Likely benign (Oct 01, 2022)2648886
19-1041416-C-T not specified Uncertain significance (Aug 09, 2021)2410272
19-1041541-T-C Likely benign (Feb 16, 2018)715315
19-1041613-C-G Likely benign (Dec 14, 2018)752423
19-1041829-A-T Alzheimer disease 9 Uncertain significance (-)1339045
19-1041910-C-T Likely benign (Jul 21, 2018)763780
19-1041940-GC-G Likely pathogenic (Mar 24, 2022)1678180
19-1041972-T-G Amyotrophic lateral sclerosis Uncertain significance (Nov 10, 2022)1810281
19-1042060-C-G Likely benign (Jul 20, 2018)735421
19-1042079-A-G Likely benign (Apr 23, 2018)740361
19-1042354-C-T ABCA7-related disorder Benign (Sep 18, 2019)777342
19-1042394-C-T Likely benign (Feb 26, 2018)727265
19-1042748-A-G ABCA7-related disorder Benign (Jun 28, 2019)3043028
19-1042810-A-G Benign (Aug 22, 2019)1237748
19-1042831-G-A Likely benign (Dec 31, 2019)715540
19-1043048-C-T not specified Uncertain significance (Jun 23, 2021)2281533
19-1043053-C-T Likely benign (Dec 07, 2019)1154619
19-1043140-G-A Uncertain significance (Nov 03, 2021)1319708
19-1043153-G-A not specified Uncertain significance (Mar 11, 2024)3112755
19-1043162-T-G not specified Likely benign (Jan 03, 2024)3112768
19-1043178-C-A not specified Uncertain significance (Mar 12, 2024)3112788
19-1043184-C-T Benign (Dec 31, 2019)777343
19-1043194-G-T not specified Uncertain significance (Jan 10, 2023)2463986
19-1043197-C-G not specified Uncertain significance (Jan 17, 2024)3112865

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ABCA7protein_codingprotein_codingENST00000263094 4625470
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.11e-555.07e-7124312214341257480.00573
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.4715161.36e+31.110.000093413509
Missense in Polyphen521481.431.08225228
Synonymous-1.076496151.050.00004384708
Loss of Function0.973901010.8950.000005131043

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.02140.0204
Ashkenazi Jewish0.009290.00867
East Asian0.007230.00693
Finnish0.003430.00199
European (Non-Finnish)0.005800.00518
Middle Eastern0.007230.00693
South Asian0.004280.00406
Other0.005990.00539

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in phagocytosis by macrophages of apoptotic cells. Binds APOA1 and may function in apolipoprotein-mediated phospholipid efflux from cells. May also mediate cholesterol efflux. May regulate cellular ceramide homeostasis during keratinocytes differentiation. {ECO:0000269|PubMed:12917409, ECO:0000269|PubMed:12925201, ECO:0000269|PubMed:14570867, ECO:0000269|PubMed:14592415}.;
Disease
DISEASE: Alzheimer disease 9 (AD9) [MIM:608907]: A familial, late- onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C- terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. {ECO:0000269|PubMed:25807283, ECO:0000269|PubMed:26141617}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
ABC transporters - Homo sapiens (human);ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport (Consensus)

Recessive Scores

pRec
0.155

Intolerance Scores

loftool
0.0339
rvis_EVS
-2.15
rvis_percentile_EVS
1.46

Haploinsufficiency Scores

pHI
0.0555
hipred
N
hipred_score
0.144
ghis
0.520

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.392

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Abca7
Phenotype
adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); renal/urinary system phenotype;

Gene ontology

Biological process
lipid transport;phagocytosis;memory;positive regulation of cholesterol efflux;peptide cross-linking;cholesterol efflux;phospholipid efflux;high-density lipoprotein particle assembly;protein localization to nucleus;apolipoprotein A-I-mediated signaling pathway;negative regulation of amyloid precursor protein biosynthetic process;phospholipid translocation;positive regulation of phagocytosis;transmembrane transport;positive regulation of ERK1 and ERK2 cascade;positive regulation of amyloid-beta clearance;positive regulation of engulfment of apoptotic cell;negative regulation of amyloid-beta formation;positive regulation of phospholipid efflux
Cellular component
Golgi membrane;phagocytic cup;Golgi apparatus;plasma membrane;cell surface;integral component of membrane;cell junction;early endosome membrane;ruffle membrane;ATP-binding cassette (ABC) transporter complex;intracellular membrane-bounded organelle
Molecular function
transporter activity;lipid transporter activity;protein binding;ATP binding;ATPase activity;apolipoprotein A-I receptor activity;ATPase activity, coupled to transmembrane movement of substances;phosphatidylcholine-translocating ATPase activity;phosphatidylserine-translocating ATPase activity